30854 | $GTRL 0.005 | clayton | 02/07/2015 10:56:21 AM |
30853 | $GPRO 47.12 | clayton | 02/07/2015 10:53:59 AM |
30852 | $MTVX 0.0001 | clayton | 02/07/2015 10:53:30 AM |
30851 | $SUTI 0.0016 | clayton | 02/07/2015 10:50:32 AM |
30850 | $NWGC 0.0014 | clayton | 02/07/2015 10:49:30 AM |
30849 | $GRAS - WEST PALM BEACH, FL--(Marketwired - Dec | zipcash | 02/07/2015 10:27:25 AM |
30848 | $MRNJ @ .0007! | Estrella | 02/06/2015 1:39:27 PM |
30847 | $POOSF @ .001! | Estrella | 02/06/2015 1:03:23 PM |
30846 | $SDVI @ .0001! | Estrella | 02/06/2015 12:47:46 PM |
30845 | $MDHI .12pps undervalued. | $maker | 02/06/2015 12:34:35 PM |
30844 | $IDNG @ .0033! | Estrella | 02/06/2015 12:11:15 PM |
30843 | $IDNG @ .002! | Estrella | 02/06/2015 12:09:15 PM |
30842 | $STOY - Mobile apps revenues are expected to hit | stockman69 | 02/06/2015 11:37:55 AM |
30841 | $STOY - Mobile apps and connectivity companies | stockman69 | 02/06/2015 11:37:08 AM |
30840 | $RXMD @ .03! | Estrella | 02/06/2015 11:31:11 AM |
30839 | $RXMD @ .026! | Estrella | 02/06/2015 11:01:43 AM |
30838 | $NECA @ .0003! | Estrella | 02/06/2015 10:57:08 AM |
30837 | $ADNY @ .0011! | Estrella | 02/06/2015 10:54:11 AM |
30836 | $ADNY @ .001! | Estrella | 02/06/2015 10:53:41 AM |
30835 | $CABN @ .0076! | Estrella | 02/06/2015 9:32:41 AM |
30834 | $CWIR @ .0008! | Estrella | 02/05/2015 1:23:34 PM |
30833 | $CWIR @ .0005! | Estrella | 02/05/2015 11:26:19 AM |
30832 | $TRAB @ .002! | Estrella | 02/05/2015 11:16:52 AM |
30831 | $QLTS @ .0036! | Estrella | 02/05/2015 11:06:01 AM |
30830 | $TRAB @ .0019! | Estrella | 02/05/2015 10:48:18 AM |
30829 | $TRAB @ .0016! | Estrella | 02/05/2015 10:47:04 AM |
30828 | RDXH .06 | supremeballer | 02/05/2015 9:22:34 AM |
30827 | $SEWC @ .0005! | Estrella | 02/04/2015 3:41:11 PM |
30826 | $SNDN @ .0015! | Estrella | 02/04/2015 2:49:59 PM |
30825 | RDXH .05 volume! .05 just wiped off the | supremeballer | 02/04/2015 10:05:30 AM |
30824 | $GNPT 0.0135 | clayton | 02/03/2015 2:05:08 PM |
30823 | $GRCU 0.0057 | clayton | 02/03/2015 1:44:47 PM |
30822 | $FXCM 2.05 | clayton | 02/03/2015 1:44:14 PM |
30821 | $FITX 0.0086 | clayton | 02/03/2015 1:37:01 PM |
30820 | $ECIG 0.0565 | clayton | 02/03/2015 1:26:51 PM |
30819 | $NOW 71.98 | clayton | 02/03/2015 1:22:14 PM |
30818 | $ESPR 50.24 | clayton | 02/03/2015 1:21:41 PM |
30817 | $IFCR 0.0055 | clayton | 02/03/2015 1:20:39 PM |
30816 | $BITA 57.34 | clayton | 02/03/2015 1:13:43 PM |
30815 | $SSYS 53.39 | clayton | 02/03/2015 1:13:16 PM |
30814 | $OCLG 0.0087 | clayton | 02/03/2015 1:12:25 PM |
30813 | $GILD 104.91 | clayton | 02/03/2015 1:03:21 PM |
30812 | $DIRV 0.0008 | clayton | 02/03/2015 12:53:26 PM |
30811 | $XLP 48.78 | clayton | 02/03/2015 12:52:46 PM |
30810 | $TRTC 0.26 | clayton | 02/03/2015 12:51:12 PM |
30809 | $CSIQ 26.17 | clayton | 02/03/2015 12:50:09 PM |
30808 | $SSYS 53.39 | clayton | 02/03/2015 12:48:47 PM |
30807 | $CNQ.TO | clayton | 02/03/2015 12:42:18 PM |
30806 | $EPGL 0.054 | clayton | 02/03/2015 12:39:54 PM |
30805 | $MSMY 0.0011 | clayton | 02/03/2015 12:35:29 PM |
Recent Articles
- IRS Clarifies No New Stimulus Checks Will Be Issued This Year
- CTO Realty Growth Investors: Act Now for Class Action Rights
- Danielle Panabaker's Crossover Experience: Pay Issues Revealed
- New Forever Stamp Celebrates Legacy of Former President Carter
- XPPen Marks 20 Years of Innovation and Creativity in Art
- Investigation Launched for Investors of GSK plc Amid Concerns
- Unraveling Investor Concerns Involving Confluent, Inc. Stock
- Investigation into Neogen Corporation Raises Concerns for Investors
- Class Action Filed Against Alto Neuroscience Over IPO Misrepresentation
- Class Action Lawsuit Announced Against Hims & Hers Health, Inc.
- Understanding the Legal Landscape for PetMed Investors
- Class Action Filed Against Flywire Corporation: A Legal Overview
- Investigation into Unicycive Therapeutics Raises Consumer Concerns
- Join the Class Action Against XPLR Infrastructure: Your Rights Matter
- Dyne Therapeutics Faces Investigations Over Alleged Fraud Claims
- iRobot Faces Class Action Lawsuit as Investor Confidence Wanes
- Ricardo Salinas Plans Full Bitcoin Investment Strategy
- Investigation Announced for Geely Automobile Holdings Investors
- Capricor Therapeutics Faces Investigation Amid Stock Concerns
- Important Updates for Investors in Fiserv, Inc. Lawsuit
- Investors Alerted: Class Action Lawsuit Against RxSight, Inc.
- Reddit Faces Legal Action Amidst Declining User Rates
- Major Class Action Opportunity for Charter Communications Investors
- Understanding the Replimune Group Class Action Lawsuit Process
- Trump and Putin: A Controversial Conversation on Election Integrity
- Investors Alert: Class Action Filed Against Biohaven Ltd.
- Investigation into Barnes & Noble Education Sparks Concern
- Simulations Plus Faces Scrutiny Amidst Financial Challenges
- Tesla Faces Class Action Lawsuit Amidst Controversial Robotaxi Launch
- Exploring Legal Investigations into Dow Inc. for Investors
- Investigation into Tronox Holdings: Examining Recent Developments
- Albany International Corp. Faces Investor Scrutiny Amid Concerns
- Inspire Medical Systems on the Radar as Stock Drops Significantly
- Spectrum Pharmaceuticals Faces Class Action Lawsuit Reminder
- Lockheed Martin Faces Class Action Amidst Losses and Lawsuit
- Mohamed bin Zayed University Welcomes Record Student Cohort
- What is Ethereum? A Simple Guide for New Crypto Users
- Investigation into Altimmune, Inc. Potential Securities Violations
- American Outdoor Brands: Investigating Claims For Investors
- Investigation into BellRing Brands, Inc. Raises Concerns for Investors
- Investor Insights: Harrow Inc. Investigated for Securities Fraud
- Investigation into Funko, Inc. by Pomerantz Law Firm
- Investors Urged to Learn About Mereo BioPharma's Situation
- Investigation into Charter Communications Raises Concerns
- Investor Concerns Grow for Anika Therapeutics Amid Legal Scrutiny
- Understanding the Recent Class Action Against Novo Nordisk
- Legal Investigation of Zeekr Intelligent Technology Holding
- Investor Advocacy: Understanding Telix Pharmaceuticals' Recent Events
- Exelixis Faces Investor Scrutiny Amid Financial Reporting Concerns
- Investigation Into NeoGenomics, Inc. Sparks Legal Interest